NBSE - NeuBase Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NBSE is currently covered by 3 analysts with an average price target of $120.58. This is a potential upside of $120.2 (31631.58%) from yesterday's end of day stock price of $0.38.

NeuBase Therapeutics's activity chart (see below) currently has 9 price targets and 12 ratings on display. The stock rating distribution of NBSE is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 92.75 days.

Highest price target for NBSE is $23, Lowest price target is $6, average price target is $120.58.

Most recent stock forecast was given by HARTAJ SINGH from OPPENHEIMER on 21-Oct-2022. First documented stock forecast 29-Oct-2019.

Best performing analysts who are covering NBSE - NeuBase Therapeutics:

Keay Nakae Brian Abrahams Hartaj Singh Raghuram Selvaraju

Currently out of the existing stock ratings of NBSE, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$280

2 years 3 months 20 days ago
(21-Oct-2022)

0/1 (0%)

$153.6 (121.52%)

Buy

2 years 3 months 24 days ago
(17-Oct-2022)

0/2 (0%)

$255.8 (245.49%)

Buy

$360

2 years 8 months 10 days ago
(31-May-2022)

0/2 (0%)

$126.2 (53.98%)

Buy

$15

$14 (1400.00%)

$320

3 years 5 months 25 days ago
(16-Aug-2021)

1/2 (50%)

$-54.8 (-78.51%)

371

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NBSE (NeuBase Therapeutics) average time for price targets to be met?

On average it took 92.75 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on NBSE (NeuBase Therapeutics) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on NBSE (NeuBase Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on NBSE (NeuBase Therapeutics)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 6 ratings on NBSE

Which analyst is the currently most bullish on NBSE (NeuBase Therapeutics)?

Brian Abrahams with highest potential upside - $14

Which analyst is the currently most reserved on NBSE (NeuBase Therapeutics)?

Keay Nakae with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?